We demonstrated that CFW and MBW can be potential therapeutic agents for preventing testosterone-deficiency syndrome and osteoarthritis risk and that they suppress inflammation in the knee joint, which protects against the decrease in BMD, LBM, and insulin sensitivity in a testosterone-deficient animal model. The gene discussed is INS; the disease is osteoarthritis.